MOG antibody disease (MOGAD)
A recently identified neuro-inflammatory illness called MOG antibody disease (MOGAD) mainly induces inflammation in the optic nerve but can also do so in the spinal cord and brain. The central nervous system's myelin sheaths include a protein called myelin oligodendrocyte glycoprotein (MOG). MOG is a target of the immune system in this condition, despite the fact that the exact function of this glycoprotein is unknown. When patients with recurrent inflammatory episodes of the central nervous system have MOG antibodies in their blood, the diagnosis is established.
Related Conference of MOG antibody disease (MOGAD)
June 22-23, 2026
18th Global Neurologists Meeting on Neurology and Neurosurgery
Amsterdam, Netherlands
June 29-30, 2026
31st International Conference on Neurology: Neurochemistry, Neuropharmacology and Neurosciences
Paris, France
July 20-21, 2026
11th International Conference on Central Nervous System Disorders & Therapeutics
Amsterdam, Netherlands
July 23-24, 2026
14th International Conference on Cannabis & Medicinal Research
Amsterdam, Netherlands
September 17-18, 2026
31st Global Experts Meeting on Neuroscience and Neuropharmacology
Paris, France
April 27-28, 2027
18th International Conference on Stroke, Neurology and Cerebrovascular Diseases
Paris, France